New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
11:32 EDTRELVReliv acquires exclusive rights to lunasin
Reliv announced that it has entered into an exclusive license for the intellectual property of Soy Labs related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soy's documented health benefits, from cholesterol reduction to general cellular health. The license covers an issued patent and several patent applications related to lunasin and soy-related peptides, proprietary information and manufacturing processes of Soy Labs. Further, the arrangement allows certain Soy Labs employees to join the Reliv corporate staff.The License Agreement is for a term covering the entire period of the basic patent and then provides for a full assignment of all of the technology rights to Reliv. Reliv will make minimum payments of $1.15M initially and additional minimum payments over a five year period totaling $850,000. In addition, Reliv will pay a royalty at varying rates over the term of the agreement.
News For RELV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RELV

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use